Welcome to our dedicated page for Biorem news (Ticker: BIRMF), a resource for investors and traders seeking the latest updates and insights on Biorem stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Biorem's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Biorem's position in the market.
BIOREM Inc. announced new orders totaling $7.1 million, increasing its record order backlog to $44.5 million. This growth reflects the success of its new air emission abatement technologies and services. Orders, mostly in the $1M to $2M range, are expected to convert into revenue within a year. The company also reported a $1.3 million order for services, bringing year-to-date service orders to $5.3 million. The market for air emissions abatement is projected to grow at an annual rate of 5.4%, reaching $1.6 billion by 2027.
FAQ
What is the current stock price of Biorem (BIRMF)?
What is the market cap of Biorem (BIRMF)?
